Literature DB >> 27633338

Total Synthesis of Aspergillomarasmine A and Related Compounds: A Sulfamidate Approach Enables Exploration of Structure-Activity Relationships.

Silvia A Albu1, Kalinka Koteva2, Andrew M King2, Salma Al-Karmi1, Gerard D Wright3, Alfredo Capretta4,5.   

Abstract

The fungal secondary metabolite aspergillomarasmine A (AMA) has recently been identified as an inhibitor of metallo-β-lactamases NDM-1 and VIM-2. Described herein is an efficient and practical route to AMA and its related compounds by a sulfamidate approach. In addition, a series of derivatives has been prepared and tested for biological activity in an effort to explore preliminary structure activity relationships. While it was determined that natural LLL isomer of AMA remains the most effective inactivator of NDM-1 enzyme activity both in vitro and in cells, the structure is highly tolerant of the changes in the stereochemistry at positions 3, 6, and 9.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antibiotics; enzymes; inhibitors; lactams; total synthesis

Mesh:

Substances:

Year:  2016        PMID: 27633338     DOI: 10.1002/anie.201606657

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  11 in total

1.  Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo-β-Lactamases.

Authors:  Allie Y Chen; Pei W Thomas; Zishuo Cheng; Nasa Y Xu; David L Tierney; Michael W Crowder; Walter Fast; Seth M Cohen
Journal:  ChemMedChem       Date:  2019-05-24       Impact factor: 3.466

Review 2.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

Review 3.  The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism Matters.

Authors:  Lin-Cheng Ju; Zishuo Cheng; Walter Fast; Robert A Bonomo; Michael W Crowder
Journal:  Trends Pharmacol Sci       Date:  2018-04-18       Impact factor: 14.819

4.  Iminodiacetic Acid as a Novel Metal-Binding Pharmacophore for New Delhi Metallo-β-lactamase Inhibitor Development.

Authors:  Allie Y Chen; Caitlyn A Thomas; Pei W Thomas; Kundi Yang; Zishuo Cheng; Walter Fast; Michael W Crowder; Seth M Cohen
Journal:  ChemMedChem       Date:  2020-05-07       Impact factor: 3.466

5.  Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.

Authors:  Shui Liu; Jian Zhang; Yonglin Zhou; Naiyu Hu; Jiyun Li; Yang Wang; Xiaodi Niu; Xuming Deng; Jianfeng Wang
Journal:  Br J Pharmacol       Date:  2019-12-09       Impact factor: 8.739

Review 6.  β-lactam/β-lactamase inhibitor combinations: an update.

Authors:  Kamaleddin H M E Tehrani; Nathaniel I Martin
Journal:  Medchemcomm       Date:  2018-08-17       Impact factor: 3.597

Review 7.  Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health.

Authors:  Asad U Khan; Lubna Maryam; Raffaele Zarrilli
Journal:  BMC Microbiol       Date:  2017-04-27       Impact factor: 3.605

8.  Magnolol restores the activity of meropenem against NDM-1-producing Escherichia coli by inhibiting the activity of metallo-beta-lactamase.

Authors:  Shui Liu; Yonglin Zhou; Xiaodi Niu; Tingting Wang; Jiyun Li; Zhongjie Liu; Jianfeng Wang; Shusheng Tang; Yang Wang; Xuming Deng
Journal:  Cell Death Discov       Date:  2018-02-20

9.  Nickel-Catalyzed Asymmetric Hydrogenation of Cyclic Sulfamidate Imines: Efficient Synthesis of Chiral Cyclic Sulfamidates.

Authors:  Yuanhua Liu; Zhiyuan Yi; Xuefeng Tan; Xiu-Qin Dong; Xumu Zhang
Journal:  iScience       Date:  2019-07-04

10.  Three-Dimensional Structure and Optimization of the Metallo-β-Lactamase Inhibitor Aspergillomarasmine A.

Authors:  Kalinka Koteva; David Sychantha; Caitlyn M Rotondo; Christian Hobson; James F Britten; Gerard D Wright
Journal:  ACS Omega       Date:  2022-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.